EMEA-001342-PIP01-12 - paediatric investigation plan

atorvastatin

Ramipril

acetyl salicylic acid

Key facts

• Active Substance:
  • atorvastatin
  • Ramipril
  • acetyl salicylic acid
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0247/2012
• PIP number:
  EMEA-001342-PIP01-12
• Pharmaceutical form(s):
  Capsule, hard
• Condition(s) / indication(s):
  Treatment of cardiovascular disease
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  22/10/2012

Decision

P/0247/2012: EMA decision of 22 October 2012 on the granting of a product-specific waiver for atorvastatin / ramipril / acetyl salicylic acid (EMEA- 001342-PIP01-12)

AdoptedReference Number: EMA/587295/2012